Michelle S. Ginsberg
About
Michelle S. Ginsberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Michelle S. Ginsberg has authored 193 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 62 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michelle S. Ginsberg's work include Lung Cancer Diagnosis and Treatment (62 papers), Lung Cancer Treatments and Mutations (60 papers) and Radiomics and Machine Learning in Medical Imaging (36 papers). Michelle S. Ginsberg is often cited by papers focused on Lung Cancer Diagnosis and Treatment (62 papers), Lung Cancer Treatments and Mutations (60 papers) and Radiomics and Machine Learning in Medical Imaging (36 papers). Michelle S. Ginsberg collaborates with scholars based in United States, Ireland and United Kingdom. Michelle S. Ginsberg's co-authors include Robert J. Motzer, Mark G. Kris, Lawrence H. Schwartz, Bruce G. Redman, Sindy T. Kim, Gary R. Hudes, Charles M. Baum, Daniel J. George, George Wilding and M. Dror Michaelson and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.
In The Last Decade
Michelle S. Ginsberg
181 papers receiving 9.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Michelle S. Ginsberg United States | 51 | 6.0k | 3.5k | 3.3k | 2.1k | 1.8k | 193 | 9.5k | ||
| Christophe Massard France | 59 | 6.0k 1.0× | 7.0k 2.0× | 2.8k 0.8× | 2.5k 1.2× | 2.2k 1.2× | 432 | 12.6k | ||
| Hendrik Dienemann Germany | 52 | 4.7k 0.8× | 2.8k 0.8× | 2.3k 0.7× | 1.3k 0.6× | 1.0k 0.6× | 236 | 8.8k | ||
| Camelia S. Sima United States | 60 | 9.4k 1.6× | 6.3k 1.8× | 2.7k 0.8× | 2.0k 1.0× | 1.4k 0.8× | 169 | 13.3k | ||
| Gwénaëlle Gravis France | 41 | 6.3k 1.1× | 3.4k 1.0× | 2.2k 0.7× | 2.1k 1.0× | 1.8k 1.0× | 368 | 9.2k | ||
| Mizuki Nishino United States | 56 | 6.1k 1.0× | 5.5k 1.6× | 1.4k 0.4× | 979 0.5× | 1.7k 0.9× | 228 | 10.9k | ||
| Heather A. Wakelee United States | 60 | 7.5k 1.3× | 6.9k 2.0× | 3.9k 1.2× | 4.0k 1.9× | 1.0k 0.6× | 447 | 13.5k | ||
| Christopher G. Azzoli United States | 49 | 7.5k 1.2× | 6.0k 1.7× | 2.4k 0.7× | 1.4k 0.7× | 1.1k 0.6× | 154 | 10.2k | ||
| Beow Y. Yeap United States | 68 | 10.3k 1.7× | 7.1k 2.0× | 3.1k 0.9× | 2.2k 1.0× | 1.1k 0.6× | 206 | 14.4k | ||
| Maciej Krzakowski Poland | 43 | 6.4k 1.1× | 7.6k 2.2× | 2.2k 0.7× | 1.6k 0.8× | 785 0.4× | 261 | 11.4k | ||
| Daniel J. George United States | 37 | 5.4k 0.9× | 3.1k 0.9× | 3.4k 1.0× | 2.7k 1.3× | 751 0.4× | 255 | 7.9k |
Countries citing papers authored by Michelle S. Ginsberg
Since
Specialization
Citations
This map shows the geographic impact of Michelle S. Ginsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle S. Ginsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle S. Ginsberg more than expected).
Fields of papers citing papers by Michelle S. Ginsberg
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michelle S. Ginsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle S. Ginsberg. The network helps show where Michelle S. Ginsberg may publish in the future.
Co-authorship network of co-authors of Michelle S. Ginsberg
This figure shows the co-authorship network connecting the top 25 collaborators of Michelle S. Ginsberg. A scholar is included among the top collaborators of Michelle S. Ginsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle S. Ginsberg. Michelle S. Ginsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Cooper, A., Michelle S. Ginsberg, Lynette M. Sholl, et al.. (2025). 233P: Chemo-immunotherapy for borderline resectable and unresectable NSCLC. Journal of Thoracic Oncology. 20(3). S148–S148.
2.
Murphy, David J., Anna K. Nowak, Thomas Frauenfelder, et al.. (2025). Radiologist’s Guide to the Ninth Edition TNM Staging System for Quantitative and Qualitative Assessment of Pleural Mesothelioma. Radiology. 316(3). e250531–e250531.
3.
Offin, Michael, Michelle S. Ginsberg, Prasad S. Adusumilli, et al.. (2024). Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study.. Journal of Clinical Oncology. 42(16_suppl). 8083–8083.
4.
Marmarelis, Melina E., Xiao Wang, Leonid Roshkovan, et al.. (2023). Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma. JAMA Network Open. 6(3). e232526–e232526.
5.
Mikhail-Lette, Miriam, Diana Páez, Lawrence N. Shulman, et al.. (2022). Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine. JCO Global Oncology. 8(8). e2100100–e2100100.
6.
Pérez-Johnston, Rocío, José de Arimateia Batista Araújo-Filho, James G. Connolly, et al.. (2022). CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes. Radiology. 303(3). 664–672.
7.
Araújo-Filho, José de Arimateia Batista, Jason C. Chang, María Mayoral, et al.. (2021). Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?. Lung Cancer. 153. 158–164.
8.
Plodkowski, Andrew J., Dipti Gupta, Yulia Lakhman, et al.. (2020). Diagnostic utility and clinical implication of late gadolinium enhancement cardiac magnetic resonance for detection of catheter associated right atrial thrombus. Clinical Imaging. 62. 17–22.
9.
Halpenny, Darragh, et al.. (2020). Lung cancer screening in patients with previous malignancy: Is this cohort at increased risk for malignancy?. European Radiology. 31(1). 458–467.
10.
Bates, David D. B., et al.. (2020). Use of a portable computed tomography scanner for chest imaging of COVID-19 patients in the urgent care at a tertiary cancer center. Emergency Radiology. 27(6). 597–600.
11.
Zauderer, Marjorie G., Anne S. Tsao, Tao Dao, et al.. (2017). A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma. Clinical Cancer Research. 23(24). 7483–7489.
12.
Paik, Paul K., Alexander Drilon, Pang‐Dian Fan, et al.. (2015). Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping. Cancer Discovery. 5(8). 842–849.
13.
Plodkowski, Andrew J., Alexander Drilon, Darragh Halpenny, et al.. (2015). From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?. Lung Cancer. 90(2). 321–325.
14.
Halpenny, Darragh, Carole A. Ridge, Sara A. Hayes, et al.. (2014). Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clinical Imaging. 39(2). 254–258.
15.
Pietanza, M. Catherine, Kyuichi Kadota, Kety Huberman, et al.. (2012). Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker. Clinical Cancer Research. 18(4). 1138–1145.
16.
Oxnard, Geoffrey R., Binsheng Zhao, Camelia S. Sima, et al.. (2011). Variability of Lung Tumor Measurements on Repeat Computed Tomography Scans Taken Within 15 Minutes. Journal of Clinical Oncology. 29(23). 3114–3119.
17.
He, Mai, Marzia Capelletti, Khédoudja Nafa, et al.. (2011). EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma. Clinical Cancer Research. 18(6). 1790–1797.
18.
Paik, Paul K., Charles M. Rudin, M. Catherine Pietanza, et al.. (2011). A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer. Lung Cancer. 74(3). 481–485.
19.
Zakowski, Maureen F., et al.. (2010). Are There Imaging Characteristics Associated with Epidermal Growth Factor Receptor and KRAS Mutations in Patients with Adenocarcinoma of the Lung with Bronchioloalveolar Features?. Journal of Thoracic Oncology. 5(3). 344–348.
20.
Motzer, Robert J., M. Dror Michaelson, Bruce G. Redman, et al.. (2005). Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 24(1). 16–24.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Christophe Massard Breakdown of academic impact, for papers by Hendrik Dienemann Breakdown of academic impact, for papers by Camelia S. Sima Breakdown of academic impact, for papers by Gwénaëlle Gravis Breakdown of academic impact, for papers by Mizuki Nishino Breakdown of academic impact, for papers by Heather A. Wakelee Breakdown of academic impact, for papers by Christopher G. Azzoli Breakdown of academic impact, for papers by Beow Y. Yeap Breakdown of academic impact, for papers by Maciej Krzakowski Breakdown of academic impact, for papers by Daniel J. George